Mutual of America Capital Management’s Kenvue KVUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.77M Sell
197,244
-6,178
-3% -$109K 0.04% 548
2026
Q1
$3.51M Sell
203,422
-1,935
-0.9% -$34.5K 0.04% 526
2025
Q4
$3.54M Sell
205,357
-2,310
-1% -$37.8K 0.04% 560
2025
Q3
$3.37M Sell
207,667
-12,182
-6% -$249K 0.04% 592
2025
Q2
$4.6M Sell
219,849
-73,973
-25% -$1.68M 0.05% 470
2025
Q1
$7.05M Sell
293,822
-55,866
-16% -$1.24M 0.08% 275
2024
Q4
$7.47M Buy
349,688
+27,480
+9% +$623K 0.08% 277
2024
Q3
$7.45M Buy
322,208
+4,704
+1% +$97.5K 0.08% 280
2024
Q2
$5.77M Buy
317,504
+91,398
+40% +$1.77M 0.06% 374
2024
Q1
$4.85M Sell
226,106
-6,696
-3% -$136K 0.05% 493
2023
Q4
$5.01M Sell
232,802
-10,157
-4% -$203K 0.06% 443
2023
Q3
$4.88M Buy
+242,959
New +$5.62M 0.06% 412

Other funds holding KVUE

Mutual of America Capital Management's KVUE Position: Q2 2026 in Review

Mutual of America Capital Management reduced its Kenvue (KVUE) stake by 3% in Q2 2026, selling an estimated $109K and leaving 197,244 shares worth $3.77M. The position accounts for 0.04% of the portfolio, ranked #548.

Mutual of America Capital Management first reported a position in KVUE in Q3 2023 and has held it in 12 quarters since. The position peaked at $7.47M in Q4 2024. 1,004 funds tracked by Wall St. Rank hold KVUE as of Q2 2026.

  • Mutual of America Capital Management held 197,244 shares of Kenvue worth $3.77M as of Q2 2026.
  • Mutual of America Capital Management sold 6,178 Kenvue shares in Q2 2026, an estimated $109K.
  • Kenvue made up 0.04% of Mutual of America Capital Management's portfolio in Q2 2026, its #548 holding.
  • Mutual of America Capital Management first reported a position in Kenvue in Q3 2023 and has held it in 12 quarters since.
  • Mutual of America Capital Management's Kenvue position peaked at $7.47M in Q4 2024.
  • 1,004 funds tracked by Wall St. Rank held Kenvue as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.